UBS Oncology Impact Fund, 10% Owner: Werewolf Therapeutics HOWL Sell · Filed 25/11/20

Trade details

Type: Insider sale
Amount: $62,344.56
Shares · price: 66,324 sh · $0.94 a share
Held after: 5,362,588 sh
Stock: Werewolf Therapeutics HOWL
Person: UBS Oncology Impact Fund10% Owner
Trade date: 25/11/19
Filed: 25/11/20
Days to filing: 1 days

Sold 1.2% of holdings

Share of holding sold: 1.2%

Werewolf Therapeutics trades, last 26 weeks

What else happened in Werewolf Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/20~25/12/19

UBS Oncology Impact Fund's recent trades

UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$27.3K
80,142 sh
$27.3K
Filed 07/06
Traded 07/06
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$28.4K
87,916 sh
$28.4K
Filed 06/29
Traded 06/29
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$99K
202,029 sh
$99K
Filed 05/28
Traded 05/28
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$123.8K
240,280 sh
$123.8K
Filed 05/18
Traded 05/18
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$47.5K
69,904 sh
$47.5K
Filed 05/11
Traded 05/11